keyword
https://read.qxmd.com/read/38655360/green-finance-and-high-pollution-corporate-compensation-empirical-evidence-from-green-credit-guidelines
#21
JOURNAL ARTICLE
Shiyu Li, Deqin Lin, Hongfei Xiao
With the increasing focus on Environmental, Social, and Governance (ESG) and Corporate Social Responsibility (CSR) on a global scale, stakeholders expect businesses to transform and enhance social responsibility. Over time, ESG and CSR have developed into vital performance metrics for businesses. Businesses are actively putting improvement measures into place in response to this new paradigm in order to stay competitive in this changing environment. China's dual commitment to CSR and sustainable development is in line with wider objectives, such as resolving issues of pay inequality...
April 30, 2024: Heliyon
https://read.qxmd.com/read/38655299/exploring-the-neuroprotection-of-the-combination-of-astragaloside-a-chlorogenic-acid-and-scutellarin-in-treating-chronic-cerebral-ischemia-via-network-analysis-and-experimental-validation
#22
JOURNAL ARTICLE
Fang Cheng, Jie Zhang, Pan Yang, Zufei Chen, Yinghao Fu, Jiajia Mi, Xingliang Xie, Sha Liu, Yanmei Sheng
Chronic cerebral ischemia (CCI) primarily causes cognitive dysfunction and other neurological impairments, yet there remains a lack of ideal therapeutic medications. The preparation combination of Astragalus membranaceus (Fisch.) Bunge and Erigeron breviscapus (Vant.) Hand.-Mazz have been utilized to ameliorate neurological dysfunction following cerebral ischemia, but material basis of its synergy remains unclear. The principal active ingredients and their optimal proportions in this combination have been identified through the oxygen and glucose deprivation (OGD) cell model, including astragaloside A, chlorogenic acid and scutellarin (ACS), and its efficacy in enhancing the survival of OGD PC12 cells surpasses that of the combination preparation...
April 30, 2024: Heliyon
https://read.qxmd.com/read/38655206/discovery-of-anti-cd47-peptides-as-innate-immune-checkpoint-inhibitors
#23
JOURNAL ARTICLE
Bahaa Mustafa, John Fetse, Sashi Kandel, Chien-Yu Lin, Pratik Adhikary, Umar-Farouk Mamani, Yanli Liu, Mohammed Nurudeen Ibrahim, Mohammed Alahmari, Kun Cheng
Cancer immunotherapy targeting adaptive immune cells has been attracting considerable interest due to its great success in treating multiple cancers. Recently, there is also increasing interest in agents that can stimulate innate immune cell activities. Immune checkpoint inhibitors targeting innate immune cells can block inhibitory interactions ('don't eat me' signals) between tumor cells and phagocytes. CD47 is a transmembrane protein overexpressed in various cancers and acts as a potent 'do not eat me' signal that contributes to the immune evasion of cancer cells...
December 2023: Advanced Therapeutics
https://read.qxmd.com/read/38655187/the-biased-apelin-receptor-agonist-mm07-reverses-sugen-hypoxia-induced-pulmonary-arterial-hypertension-as-effectively-as-the-endothelin-antagonist-macitentan
#24
JOURNAL ARTICLE
Thomas L Williams, Duuamene Nyimanu, Rhoda E Kuc, Richard Foster, Robert C Glen, Janet J Maguire, Anthony P Davenport
Introduction: Pulmonary arterial hypertension (PAH) is characterised by endothelial dysfunction and pathological vascular remodelling, resulting in the occlusion of pulmonary arteries and arterioles, right ventricular hypertrophy, and eventually fatal heart failure. Targeting the apelin receptor with the novel, G protein-biased peptide agonist, MM07, is hypothesised to reverse the developed symptoms of elevated right ventricular systolic pressure and right ventricular hypertrophy. Here, the effects of MM07 were compared with the clinical standard-of-care endothelin receptor antagonist macitentan...
2024: Frontiers in Pharmacology
https://read.qxmd.com/read/38654934/metal-organic-framework-mediated-sirna-delivery-and-sonodynamic-therapy-for-precisely-triggering-ferroptosis-and-augmenting-icd-in-osteosarcoma
#25
JOURNAL ARTICLE
Ningxiang Sun, Qingjian Lei, Meng Wu, Shijie Gao, Zhiqiang Yang, Xuan Lv, Renxiong Wei, Feifei Yan, Lin Cai
The complex genomics, immunosuppressive tumor microenvironment (TME), and chemotherapeutic resistance of osteosarcoma (OS) have resulted in limited therapeutic effects in the clinic. Ferroptosis is involved in tumor progression and is regulated mainly by glutathione peroxidase 4 (GPX4). Small interfering RNA (siRNA)-based RNA interference (RNAi) can precisely target any gene. However, achieving effective siRNA delivery is highly challenging. Here, we fabricated a TME-responsive metal-organic framework (MOF)-based biomimetic nanosystem (mFeP@si) with siGPX4 delivery and sonodynamic therapy (SDT) to treat OS by targeting ferroptosis...
June 2024: Materials today. Bio
https://read.qxmd.com/read/38654933/zwitterionic-polymer-dexamethasone-conjugates-penetrate-and-protect-cartilage-from-inflammation
#26
JOURNAL ARTICLE
Patrick Weber, Maryam Asadikorayem, František Surman, Marcy Zenobi-Wong
Improving the pharmacokinetics of intra-articularly injected therapeutics is a major challenge in treating joint disease. Small molecules and biologics are often cleared from the joint within hours, which greatly reduces their therapeutic efficacy. Furthermore, they are often injected at high doses, which can lead to local cytotoxicity and systemic side effects. In this study, we present modular polymer-drug conjugates of zwitterionic poly(carboxybetaine acrylamide) (pCBAA) and the anti-inflammatory glucocorticoid dexamethasone (DEX) to create cartilage-targeted carriers with slow-release kinetics...
June 2024: Materials today. Bio
https://read.qxmd.com/read/38654796/intravitreal-ozurdex-vs-intravitreal-bevacizumab-for-diabetic-macular-edema-a-comprehensive-review
#27
REVIEW
Raina Jain, Sachin Daigavane
This comprehensive review examines the efficacy, safety, and implications of intravitreal OZURDEX and intravitreal bevacizumab in treating diabetic macular edema (DME). DME is a common complication of diabetes mellitus and a leading cause of vision loss. OZURDEX, through sustained release of dexamethasone, targets inflammation and vascular permeability, while bevacizumab inhibits vascular endothelial growth factor (VEGF), reducing angiogenesis. However, differences in safety profiles exist, with OZURDEX associated with an increased risk of intraocular pressure elevation and cataract formation and bevacizumab potentially carrying systemic risks...
March 2024: Curēus
https://read.qxmd.com/read/38654751/a-comprehensive-review-of-ethnomedicinal-uses-phytochemistry-pharmacology-and-toxicity-of-prunus-africana-hook-f-kalkman-from-africa
#28
REVIEW
James K Ndung'u, Joseph M Nguta, Isaac M Mapenay, Gervason A Moriasi
Prunus africana , a widely utilized medicinal plant in various African ethnic communities, continues to hold significant importance in traditional healing practices. Research has identified phytochemical compounds in this plant, exhibiting diverse pharmacological activities that offer potential for pharmaceutical development. Notably, P. africana is employed in treating various ailments such as wounds, diabetes mellitus, malaria, benign prostatic hyperplasia, chest pain, and prostate cancer. Its pharmacological properties are attributed to a spectrum of bioactive compounds, including tannins, saponins, alkaloids, flavonoids, terpenoids, phytosterols, and fatty acids...
2024: Scientifica
https://read.qxmd.com/read/38654731/healing-wounded-trees-clinicians-perspectives-on-treatment-of-complex-posttraumatic-stress-disorder
#29
JOURNAL ARTICLE
Boris Drožđek, Jan Rodenburg
While treatment guidelines agree on the first-line interventions for the treatment of posttraumatic stress disorder (PTSD), there is an ongoing debate between experts regarding the treatment of complex posttraumatic stress disorder (C-PTSD). As scientific research is slowly emerging, different treatment approaches are used in clinical practice This article aims to provide a set of treatment options for C-PTSD in adult survivors of repeated exposure to severe violence and abuse, both in childhood and later on in life...
2024: Frontiers in Psychiatry
https://read.qxmd.com/read/38654616/prognostic-impact-of-genetic-abnormalities-in-536-first-line-chronic-lymphocytic-leukaemia-patients-without-17p-deletion-treated-with-chemoimmunotherapy-in-two-prospective-trials-focus-on-ighv-mutated-subgroups-a-filo-study
#30
JOURNAL ARTICLE
Florence Nguyen-Khac, Marine Baron, Romain Guièze, Pierre Feugier, Alexandra Fayault, Sophie Raynaud, Xavier Troussard, Nathalie Droin, Frederik Damm, Luce Smagghe, Santos Susin, Véronique Leblond, Caroline Dartigeas, Eric Van den Neste, Stéphane Leprêtre, Olivier A Bernard, Damien Roos-Weil
The potential prognostic influence of genetic aberrations on chronic lymphocytic leukaemia (CLL) can vary based on various factors, such as the immunoglobulin heavy variable (IGHV) status. We conducted an integrative analysis on genetic abnormalities identified through cytogenetics and targeted next-generation sequencing in 536 CLL patients receiving first-line chemo(immuno)therapies (CIT) as part of two prospective trials. We evaluated the prognostic implications of the main abnormalities, with specific attention to their relative impact according to IGHV status...
April 23, 2024: British Journal of Haematology
https://read.qxmd.com/read/38654600/the-bundle-wire-technique-a-novel-approach-to-cannulating-challenging-target-vessels-using-multiple-fine-atraumatic-guidewires-that-together-serve-as-a-stiff-guidewire
#31
JOURNAL ARTICLE
Ahmed A Ali, Jan Stana, Salvatore Bruno, George Joseph, Ahmed Eleshra, Nikolaos Tsilimparis
PURPOSE: To present a novel technique that enables safe and effective cannulation of target vessels with challenging anatomy during fenestrated/branched endovascular aortic repair (F/B-EVAR). TECHNIQUE: Following deployment of the F/B-EVAR endograft, the target vessels (TVs) are cannulated. The bundle wire technique provides a solution to challenging TVs and uses multiple fine atraumatic guidewires that together serve as a stiff guidewire. The technique can be executed in 2 ways using: (1) one 0...
April 23, 2024: Journal of Endovascular Therapy
https://read.qxmd.com/read/38654453/lncrna-part1-attenuates-myocardial-ischemia-reperfusion-injury-by-regulating-tfap2c-dusp5-axis-via-mir-302a-3p
#32
JOURNAL ARTICLE
Min Zeng, Xin Wei, Jinchao Zhou, Siqi Luo
BACKGROUND AND OBJECTIVES: Myocardial ischemia-reperfusion injury (MIRI) refers to the damage of cardiac function caused by restoration of blood flow perfusion in ischemic myocardium. However, long non-coding RNA prostate androgen regulated transcript 1 (PART1)'s role in MIRI remain unclear. METHODS: Immunofluorescence detected LC3 expression. Intermolecular relationships were verified by dual luciferase reporter assay. 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide, flow cytometry and transferase-mediated dUTP nick-end labeling (TUNEL) assays analyzed cell viability and apoptosis...
March 25, 2024: Korean Circulation Journal
https://read.qxmd.com/read/38654320/circcdyl2-bolsters-radiotherapy-resistance-in-nasopharyngeal-carcinoma-by-promoting-rad51-translation-initiation-for-enhanced-homologous-recombination-repair
#33
JOURNAL ARTICLE
Hongke Qu, Yumin Wang, Qijia Yan, Chunmei Fan, Xiangyan Zhang, Dan Wang, Can Guo, Pan Chen, Lei Shi, Qianjin Liao, Ming Zhou, Fuyan Wang, Zhaoyang Zeng, Bo Xiang, Wei Xiong
BACKGROUND: Radiation therapy stands to be one of the primary approaches in the clinical treatment of malignant tumors. Nasopharyngeal Carcinoma, a malignancy predominantly treated with radiation therapy, provides an invaluable model for investigating the mechanisms underlying radiation therapy resistance in cancer. While some reports have suggested the involvement of circRNAs in modulating resistance to radiation therapy, the underpinning mechanisms remain unclear. METHODS: RT-qPCR and in situ hybridization were used to detect the expression level of circCDYL2 in nasopharyngeal carcinoma tissue samples...
April 23, 2024: Journal of Experimental & Clinical Cancer Research: CR
https://read.qxmd.com/read/38654318/choroid-plexus-immune-cell-response-in-murine-hydrocephalus-induced-by-intraventricular-hemorrhage
#34
JOURNAL ARTICLE
Yingfeng Wan, Xiongjie Fu, Tianjie Zhang, Ya Hua, Richard F Keep, Guohua Xi
BACKGROUND: Intraventricular hemorrhage (IVH) and associated hydrocephalus are significant complications of intracerebral and subarachnoid hemorrhage. Despite proximity to IVH, the immune cell response at the choroid plexus (ChP) has been relatively understudied. This study employs CX3 CR-1GFP mice, which marks multiple immune cell populations, and immunohistochemistry to outline that response. METHODS: This study had four parts all examining male adult CX3 CR-1GFP mice...
April 23, 2024: Fluids and Barriers of the CNS
https://read.qxmd.com/read/38654286/exploring-the-role-of-histone-deacetylase-and-histone-deacetylase-inhibitors-in-the-context-of-multiple-myeloma-mechanisms-therapeutic-implications-and-future-perspectives
#35
REVIEW
Jingjing Pu, Ting Liu, Xuzhen Wang, Amit Sharma, Ingo G H Schmidt-Wolf, Liping Jiang, Jian Hou
Histone deacetylase inhibitors (HDACis) are a significant category of pharmaceuticals that have developed in the past two decades to treat multiple myeloma. Four drugs in this category have received approval from the U.S. Food and Drug Administration (FDA) for use: Panobinonstat (though canceled by the FDA in 2022), Vorinostat, Belinostat and Romidepsin. The efficacy of this group of drugs is attributed to the disruption of many processes involved in tumor growth through the inhibition of histone deacetylase, and this mode of action leads to significant anti-multiple myeloma (MM) activity...
April 23, 2024: Experimental Hematology & Oncology
https://read.qxmd.com/read/38654163/mtor-signaling-pathway-regulation-hif-1-%C3%AE-effects-on-lps-induced-intestinal-mucosal-epithelial-model-damage
#36
JOURNAL ARTICLE
Zeyong Huang, Wenbin Teng, Liuxu Yao, Kai Xie, Suqin Hang, Rui He, Yuhong Li
BACKGROUND: Sepsis-induced small-intestinal injury is associated with increased morbidity and mortality. Our previous study and other papers have shown that HIF-1α has a protective effect on intestinal mucosal injury in septic rats. The purpose of this study is to further verify the protective effect of HIF-1α on intestinal mucosa and its molecular mechanism in vitro experiments. METHODS: Caco-2 cells were selected and experiment was divided into 2 parts...
April 23, 2024: BMC molecular and cell biology
https://read.qxmd.com/read/38654085/intelligent-berberine-loaded-erythrocytes-attenuated-inflammatory-cytokine-productions-in-macrophages
#37
JOURNAL ARTICLE
Zahra Sadat Aghili, Mauro Magnani, Mehdi Ghatrehsamani, Azar Nourian Dehkordi, Seyed Abbas Mirzaei, Mehdi Banitalebi Dehkordi
Erythrocytes are impressive tools for drug delivery, especially to macrophages. Therefore, berberine was loaded into erythrocytes using both hypotonic pre-swelling and endocytosis methods to target macrophages. Physicochemical and kinetic parameters of the resulting carrier cells, such as drug loading/release kinetics, osmotic fragility, and hematological indices, were determined. Drug loading was optimized for the study using Taguchi experimental design and lab experiments. Loaded erythrocytes were targeted to macrophages using ZnCl2 and bis-sulfosuccinimidyl-suberate, and targeting was evaluated using flow cytometry and Wright-Giemsa staining...
April 23, 2024: Scientific Reports
https://read.qxmd.com/read/38654028/simultaneous-boost-radiotherapy-versus-conventional-dose-radiotherapy-for-patients-with-newly-diagnosed-glioblastoma-a-multi-institutional-analysis
#38
MULTICENTER STUDY
Seiya Takano, Natsuo Tomita, Mayu Kuno, Masanari Niwa, Akira Torii, Taiki Takaoka, Nozomi Kita, Dai Okazaki, Shintaro Yamamoto, Tatsuya Kawai, Chikao Sugie, Yasutaka Ogawa, Kenichi Matsumoto, Kaoru Uchiyama, Shinya Otsuka, Tooru Matsui, Akifumi Miyakawa, Tomoki Mizuno, Masato Iida, Motoki Tanikawa, Mitsuhito Mase, Akio Hiwatashi
We compared survival outcomes of high-dose concomitant boost radiotherapy (HDCBRT) and conventional dose radiotherapy (CRT) for newly diagnosed glioblastoma (GB). Patients treated with intensity-modulated radiation therapy for newly diagnosed GB were included. In HDCBRT, specific targets received 69, 60, and 51 Gy in 30 fractions, while 60 Gy in 30 fractions was administered with a standard radiotherapy method in CRT. Overall survival (OS) and progression-free survival (PFS) were compared using the Log-rank test, followed by multivariate Cox analysis...
April 23, 2024: Scientific Reports
https://read.qxmd.com/read/38653983/efficacy-and-safety-of-human-umbilical-cord-derived-mesenchymal-stem-cells-in-the-treatment-of-refractory-immune-thrombocytopenia-a-prospective-single-arm-phase-i-trial
#39
JOURNAL ARTICLE
Yunfei Chen, Yanmei Xu, Ying Chi, Ting Sun, Yuchen Gao, Xueqing Dou, Zhibo Han, Feng Xue, Huiyuan Li, Wei Liu, Xiaofan Liu, Huan Dong, Rongfeng Fu, Mankai Ju, Xinyue Dai, Wentian Wang, Yueshen Ma, Zhen Song, Jundong Gu, Wei Gong, Renchi Yang, Lei Zhang
Patients with refractory immune thrombocytopenia (ITP) frequently encounter substantial bleeding risks and demonstrate limited responsiveness to existing therapies. Umbilical cord-derived mesenchymal stem cells (UC-MSCs) present a promising alternative, capitalizing on their low immunogenicity and potent immunomodulatory effects for treating diverse autoimmune disorders. This prospective phase I trial enrolled eighteen eligible patients to explore the safety and efficacy of UC-MSCs in treating refractory ITP...
April 23, 2024: Signal Transduction and Targeted Therapy
https://read.qxmd.com/read/38653979/gene-replacement-therapy-in-bietti-crystalline-corneoretinal-dystrophy-an-open-label-single-arm-exploratory-trial
#40
JOURNAL ARTICLE
Jinyuan Wang, Jinlu Zhang, Shicheng Yu, Hongyan Li, Shaohong Chen, Jingting Luo, Haibo Wang, Yuxia Guan, Haihan Zhang, Shiyi Yin, Huili Wang, Heping Li, Junle Liu, Jingyuan Zhu, Qiong Yang, Ying Sha, Chuan Zhang, Yuhang Yang, Xuan Yang, Xifang Zhang, Xiuli Zhao, Likun Wang, Liping Yang, Wenbin Wei
Bietti crystalline corneoretinal dystrophy is an inherited retinal disease caused by mutations in CYP4V2, which results in blindness in the working-age population, and there is currently no available treatment. Here, we report the results of the first-in-human clinical trial (NCT04722107) of gene therapy for Bietti crystalline corneoretinal dystrophy, including 12 participants who were followed up for 180-365 days. This open-label, single-arm exploratory trial aimed to assess the safety and efficacy of a recombinant adeno-associated-virus-serotype-2/8 vector encoding the human CYP4V2 protein (rAAV2/8-hCYP4V2)...
April 24, 2024: Signal Transduction and Targeted Therapy
keyword
keyword
48096
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.